(Q905835)

Plerixafor (English)

18 November 2016

C₂₈H₅₄N₈

1 reference

Plerixafor (English)

18 November 2016

C1CNCCNCCCN(CCNC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3

1 reference

parenteral route of administration

Plerixafor (English)

18 November 2016

16.8 milligram

route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=L03AX16

1 reference

14 February 2018

World Health Organisation international non-proprietary name

Plerixafor (English)

1 reference

Plerixafor (English)

medical condition treated

19 January 2016

acute myeloid leukemia

1 reference

Drug Indications Extracted from FAERS

2 October 2018

15 December 2008

Food and Drug Administration

1 reference

Inxight: Drugs Database

https://drugs.ncats.io/drug/S915P5499N

2 November 2018

reference URL

https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/022311s016lbl.pdf

physically interacts with

Atypical chemokine receptor 3

subject has role

agonist

1 reference

C-C motif chemokine receptor 4

17 August 2016

subject has role

agonist

1 reference

C-X-C motif chemokine receptor 4

17 August 2016

subject has role

agonist

1 reference

imported from Wikimedia project

17 August 2016

pregnancy category

US pregnancy category D

1 reference

English Wikipedia

LiverTox likelihood score

LiverTox toxicity likelihood category E

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Plerixafor

last update

12 April 2019

Commons category

Plerixafor

0 references

Identifiers

InChI

InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2

1 reference

Plerixafor (English)

18 November 2016

2 references

Plerixafor (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

110078-46-1

2 references

plerixafor (English)

18 November 2016

https://commonchemistry.cas.org/detail?cas_rn=110078-46-1

9 April 2021

1 reference

Plerixafor (English)

18 November 2016

2 references

Plerixafor (English)

18 November 2016

ChEBI ID

125354

mapping relation type

2 references

1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane (English)

3 October 2016

International Chemical Identifier

InChI

InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2

1 reference

PLERIXAFOR (English)

18 November 2016

2 references

inferred from InChIKey

1 reference

1 reference

DSSTOX compound identifier

0 references

0 references

1 reference

Plerixafor (English)

publication date

17 November 2015

1 reference

plerixafor (English)

18 November 2016

1 reference

plerixafor (English)

18 November 2016

1 reference

Plerixafor (English)

18 November 2016

1 reference

Human Metabolome Database ID

HMDB0015681

2 references

based on heuristic

inferred from InChIKey

2 references

plerixafor (English)

18 November 2016

MedlinePlus drug identifier

a609018

0 references

PatientsLikeMe treatment ID

0 references

1 reference

plerixafor (English)

18 November 2016

0 references

1 reference

1 reference

https://docs.openalex.org/download-snapshot/snapshot-data-format

Plerixafor (English)

19 January 2016

0 references

Microsoft Academic ID

0 references

1 reference

26 January 2022

UMLS CUI

C1955474

1 reference

YSO-Wikidata mapping project

plerixafor (English)

18 November 2016

0 references

1 reference